Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses

Wei Jiang1, Xiaowen Chen, Mingzhi Liao

  • 1College of Bioinformatics Science and Technology and State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.

Scientific Reports
|February 23, 2012
PubMed

Insights

This study introduces a new method to link small molecules with microRNAs (miRNAs) across 23 cancers. The developed Small Molecule-MiRNA Network (SMirN) aids in discovering new cancer drug candidates and therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Targeting microRNAs (miRNAs) with small molecules represents a novel therapeutic strategy for human diseases, especially cancers.
  • Understanding the complex interactions between small molecules and miRNAs is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To develop a high-throughput approach for identifying biological links between small molecules and miRNAs in 23 distinct cancer types.
  • To construct and analyze Small Molecule-MiRNA Networks (SMirNs) for systematic characterization of these associations.

Main Methods:

  • A novel high-throughput screening method was employed to identify interactions.
  • Small Molecule-MiRNA Networks (SMirNs) were constructed for 23 cancer types.
  • Network analysis involved partitioning molecules and miRNAs into functional modules based on connectivity.

Main Results:

  • MiRNA modules predominantly contained miRNAs with similar target genes, functions, or family memberships.
  • Small molecule modules typically comprised compounds with shared chemical structures, modes of action, or drug interactions.
  • The identified modules facilitate the discovery of potential drug candidates and repurposing opportunities for existing drugs.

Conclusions:

  • The developed approach provides a systematic framework for analyzing small molecule-miRNA interactions in cancer.
  • The constructed SMirNs offer valuable insights for accelerating drug discovery and advancing cancer therapy.
  • This methodology holds significant potential for identifying novel therapeutic strategies in oncology.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...